FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Zydus Pharmaceuticals USA Inc.'s supplemental application for Bupropion (ANDA 201567), enabling a generic version of the antidepressant to come to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Seasonal Affective Disorder
• Tobacco Use Disorder

Drugs mentioned

• bupropion (bupropion)

Snippet

SUPPL AP for BUPROPION (BUPROPION)